Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony

Parasitology

Volumn 134, Issue 12, 2007, Pages 1679-1687

  Mandal, G ^a   Wyllie, S ^b   Singh, N ^c   Sundar, S ^d   Fairlamb, A H ^b   Chatterjee, M ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antimonial resistance; Oxidative stress; Reactive oxygen species; Thiols; Visceral leishmaniasis

Indexed keywords

ANTIMONY; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOL;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEISHMANIA DONOVANI; NONHUMAN; OXIDATIVE STRESS; PARASITE ISOLATION; PHENOTYPE; PRIORITY JOURNAL; PROMASTIGOTE; SCAVENGING SYSTEM;

ANIMALS; ANTIMONY; ANTIPARASITIC AGENTS; DRUG RESISTANCE; HUMANS; HYDROGEN PEROXIDE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; REACTIVE OXYGEN SPECIES; SPECIES SPECIFICITY; SULFHYDRYL COMPOUNDS;

LEISHMANIA DONOVANI;

EID: 34948899791     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182007003150     Document Type: Article

References (34)

1. Borst, P. and Ouellette, M. (1995). New mechanisms of drug resistance in parasitic protozoa. Annual Review of Microbiology 49, 427-460.
2. Chakraborty, A. K. and Majumder, H. K. (1988). Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani. Biochemical and Biophysical Research Communications 152, 605-611.
3. Croft, S. L., Sundar, S. and Fairlamb, A. H. (2006). Drug resistance in leishmaniasis. Clinical Microbiology Reviews 19, 111-126.
4. Dey, S., Papadopoulou, B., Haimeur, A., Roy, G., Grondin, K., Dou, D., Rosen, B. P. and Ouellette, M. (1994). High level of arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Molecular and Biochemical Parasitology 67, 49-57.
5. Fairlamb, A. H. and Cerami, A. (1992). Metabolism and functions of trypanothione in the Kinetoplastida. Annual Review of Microbiology 46, 695-729.
6. Ghosh, S., Goswami, S. and Adhya, S. (2003). Role of superoxide dismutase in survival of Leishmania within the macrophage. The Biochemical Journal 369, 447-452.
7. Gottesman, M. M. (2002). Mechanisms of cancer drug resistance. Annual Review of Medicine 53, 615-627.
8. Griffith, O. W. and Meister, A. (1979). Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). Journal of Biological Chemistry 254, 7558-7560.
9. Grondin, K., Haimeur, A., Mukhopadhyay, R., Rosen, B. P. and Ouellette, M. (1997). Coamplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite resistant Leishmania tarentolae. EMBO Journal 16, 3057-3065.
10. Guerin, P. J., Olliaro, P., Sundar, S., Boelaert, M., Croft, S. L., Desjeux, P., Wasunna, M. K. and Bryceson, A. D. (2002). Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infectious Diseases 2, 494-501.
11. Haimeur, A., Brochu, C., Genest, P., Papadopoulou, B. and Ouellette, M. (2000). Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (Sb III) resistant Leishmania tarentolae. Molecular and Biochemical Parasitology 108, 131-135.
12. Haimeur, A., Guimond, C., Pilote, S., Mukhopadhyay, R., Rosen, B. P., Poulin, R. and Ouellette, M. (1999). Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite resistant Leishmania. Molecular Microbiology 34, 726-735.
13. Herwaldt, B. L. (1999). Leishmaniasis. Lancet 354, 1191-1199.
14. Jaffe, C. L., McMahon-Pratt, D. (1987). Serodiagnostic assay for visceral leishmaniasis employing monoclonal antibodies. Transactions of the Royal Society for Tropical Medicine and Hygiene 81, 587-594.
15. Lee, C. W. (2004). Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Current Medicinal Chemistry Anti-Cancer Agents 4, 43-52.
16. Lu, S. C. (2000). Regulation of glutathione synthesis. Current Topics in Cellular Regulation 36, 95-116.
17. Marquis, N., Gourbal, B., Rosen, B. P., Mukhopadhyay, R. and Ouellette, M. (2005). Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Molecular Microbiology 57, 1690-1699.
18. 2+, and glutathione. Free Radical Biology and Medicine 40, 1857-1868.
19. Meister, A. and Anderson, M. E. (1983). Glutathione. Annual Review of Biochemistry 52, 711-760.
20. Mookerjee Basu, J., Mookerjee, A., Sen, P., Bhaumik, S., Sen, P., Banerjee, S., Naskar, K., Choudhuri, S. K., Saha, B., Raha, S. and Roy, S. (2006). Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrobial Agents and Chemotherapy 50, 1788-1797.
21. Mukherjee, A., Prasad, K. P., Singh, S., Roy, G., Girard, I., Chatterjee, M., Ouellette, M. and Madhubala, R. (2007). Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. Journal of Antimicrobial Chemotherapy 59, 204-211.
22. Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., Ouellette, M. and Rosen, B. P. (1996). Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proceedings of the National Academy of Sciences, USA 93, 10383-10387.
23. Murray, H. W., Berman, J. D., Davies, C. R. and Saravia, N. G. (2005). Advances in leishmaniasis. Lancet 366, 1576-1577.
24. O'Connor, J. E., Kimler, B. F., Morgan, M. C. and Tempas, K. J. (1988). A flow cytometric assay for intracellular nonprotein thiols using mercury orange. Cytometry 9, 529-532.
25. Ouellette, M. and Borst, P. (1991). Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania. Research in Microbiology 142, 737-746.
26. Roberts, W. L. and Rainey, P. M. (1993). Antileishmanial activity of sodium stibogluconate fractions. Antimicrobial Agents and Chemotherapy 37, 1842-1846.
27. Sereno, D., Cavaleyra, M., Zemzoumi, K., Maquaire, S., Ouaissi, A. and Lemesre, J. L. (1998). Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrobial Agents and Chemotherapy 42, 3097-3102.
28. v reducing activity correlates with antimony susceptibility in Leishmania donovani. Journal of Biological Chemistry 276, 3971-3976.
29. Shim, H. and Fairlamb, A. H. (1988). Levels of polyamines, glutathione and glutathione-spermidine conjugates during growth of the insect trypanosomatid Crithidia fasciculata. Journal of General Microbiology 134, 807-817.
30. Singh, N., Almeida, R., Kothari, H., Kumar, P., Mandal, G., Chatterjee, M., Venkatachalam, S., Govind, M. K., Mandal, S. K. and Sundar, S. (2007). Differential gene expression analysis in antimony unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray. Parasitology 134, 777-787.
31. Sundar, S. and Chatterjee, M. (2006). Visceral leishmaniasis - current therapeutic modalities. Indian Journal of Medical Research 123, 345-352.
32. TDR (2005). Leishmaniasis. Seventeenth Programme Report, Progress 2003-2004, 19-25.
33. Wan, C. P., Myung, E. and Lau, B. H. (1993). An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes. Journal of Immunological Methods 159, 131-138.
34. Wyllie, S., Cunningham, M. L. and Fairlamb, A. H. (2004). Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. Journal of Biological Chemistry 279, 39925-39932.